Literature DB >> 12213413

A novel recombinant vaccine which protects mice against ricin intoxication.

Joan E Smallshaw1, Ana Firan, John R Fulmer, Stephen L Ruback, Victor Ghetie, Ellen S Vitetta.   

Abstract

Ricin toxin (RT) is a plant-derived toxin of extraordinary toxicity; a single molecule successfully internalized into the cytoplasm of a cell is lethal for that cell. An estimated dose of 1-10 microg/kg is lethal to humans, making aerosolized ricin a potential agent for bioterrorism. Vaccination against ricin using either denatured toxin or its modified A chain subunit (RTA) has been successful in experimental animals but both vaccines have potential toxicities. Recombinant (r) RTA has not been evaluated as a vaccine. However, the advantage of such a vaccine is that these potential toxicities can be deleted by appropriate mutations. In this study we have generated three mutants and shown that two lack toxicity as compared to the wild type rRTA. These mutants induce protective humoral immune responses in mice. One or both should be considered for use in humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213413     DOI: 10.1016/s0264-410x(02)00312-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  39 in total

1.  Improved stability of a protein vaccine through elimination of a partially unfolded state.

Authors:  Colleen A McHugh; Ralph F Tammariello; Charles B Millard; John H Carra
Journal:  Protein Sci       Date:  2004-08-31       Impact factor: 6.725

Review 2.  Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.

Authors:  S Ramasamy; C Q Liu; H Tran; A Gubala; P Gauci; J McAllister; T Vo
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

3.  Folding domains within the ricin toxin A subunit as targets of protective antibodies.

Authors:  Joanne M O'Hara; Lori M Neal; Elizabeth A McCarthy; Jane A Kasten-Jolly; Robert N Brey; Nicholas J Mantis
Journal:  Vaccine       Date:  2010-08-18       Impact factor: 3.641

4.  Recent advances in the development of vaccines against ricin.

Authors:  Robert N Brey; Nicholas J Mantis; Seth H Pincus; Ellen S Vitetta; Leonard A Smith; Chad J Roy
Journal:  Hum Vaccin Immunother       Date:  2016-01-25       Impact factor: 3.452

5.  RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol.

Authors:  Joan E Smallshaw; James A Richardson; Ellen S Vitetta
Journal:  Vaccine       Date:  2007-08-30       Impact factor: 3.641

6.  Structural Analysis of Single Domain Antibodies Bound to a Second Neutralizing Hot Spot on Ricin Toxin's Enzymatic Subunit.

Authors:  Michael J Rudolph; David J Vance; Michael S Cassidy; Yinghui Rong; Nicholas J Mantis
Journal:  J Biol Chem       Date:  2016-11-30       Impact factor: 5.157

7.  Pilot phase IB clinical trial of an alhydrogel-adsorbed recombinant ricin vaccine.

Authors:  Ellen S Vitetta; Joan E Smallshaw; John Schindler
Journal:  Clin Vaccine Immunol       Date:  2012-08-22

8.  Comparative efficacy of two leading candidate ricin toxin a subunit vaccines in mice.

Authors:  Joanne M O'Hara; Robert N Brey; Nicholas J Mantis
Journal:  Clin Vaccine Immunol       Date:  2013-03-20

9.  Effect of single-point mutations on the stability and immunogenicity of a recombinant ricin A chain subunit vaccine antigen.

Authors:  Justin C Thomas; Joanne M O'Hara; Lei Hu; Fei P Gao; Sangeeta B Joshi; David B Volkin; Robert N Brey; Jianwen Fang; John Karanicolas; Nicholas J Mantis; C Russell Middaugh
Journal:  Hum Vaccin Immunother       Date:  2013-04-01       Impact factor: 3.452

10.  Truncated abrin A chain expressed in Escherichia coli: a promising vaccine candidate.

Authors:  Tao Zhang; Lin Kang; Shan Gao; Hao Yang; Wenwen Xin; Junhong Wang; Maowen Guo; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2014-11-17       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.